Sumitomo Chemical
4005.TChemicals
Financials · Consolidated
| Fiscal year ended | 2026-03 | 2025-03 | 2024-03 | 2023-03 | 2022-03 | 2021-03 |
|---|---|---|---|---|---|---|
| Revenue | ¥2.33T | ¥2.61T | ¥2.45T | ¥2.90T | ¥2.77T | ¥2.29T |
| Operating income | ¥151.7bn | ¥193.0bn | −¥488.8bn | −¥31.0bn | ¥215.0bn | ¥137.1bn |
| Net income (owners) | ¥60.9bn | ¥38.6bn | −¥311.8bn | ¥7.0bn | ¥162.1bn | ¥46.0bn |
| Total assets | ¥3.41T | ¥3.44T | ¥3.93T | ¥4.17T | ¥4.31T | ¥3.99T |
| Net assets / equity | ¥1.24T | ¥1.07T | ¥1.16T | ¥1.49T | ¥1.70T | ¥1.48T |
| Operating cash flow | ¥234.8bn | ¥233.0bn | −¥51.3bn | ¥111.6bn | ¥171.7bn | ¥374.5bn |
| EPS (basic) | ¥37.16 | ¥23.59 | ¥-190.69 | ¥4.27 | ¥99.16 | ¥28.16 |
From EDINET filings. Select any figure to open the report it came from. r = changed in a later filing (the report page shows the original). — = not reported in the filings structured so far.
Reports · 2
| Period | Form | Figures |
|---|---|---|
| 2025-04-01 → 2025-09-30 | Half-year | 85 figures · EDINET |
| 2024-04-01 → 2024-09-30 | Half-year | 82 figures · EDINET |
21 more reports are still being processed.
Segments · FY ended 2026-03
| Segment | External sales | Profit |
|---|---|---|
| Advanced Medical Solutions | ¥58.6bn | ¥2.8bn |
| Agro And Life Solutions | ¥519.3bn | ¥56.3bn |
| Essential And Green Materials | ¥678.8bn | ¥14.4bn |
| ICT And Mobility Solutions | ¥574.2bn | ¥53.0bn |
| Sumitomo Pharma | ¥451.9bn | ¥108.4bn |
| Other segments | ¥45.8bn | ¥4.4bn |
| Adjustments & eliminations | — | −¥31.1bn |
| Total | ¥2.28T | ¥235.1bn |
Segment names from EDINET member IDs; not mapped to a common taxonomy.